Simrat Randhawa
Vermogen: 372 040 $ op 31-05-2026
Vermogen: 372 040 $ op 31-05-2026
Dr. Simrat Randhawa is a Head-Research and Development & Executive VP at Dianthus Therapeutics, Inc. Dr. Randhawa was previously employed as a Senior Vice President-Clinical & Medical Affairs by Aurinia Pharmaceuticals, Inc. and a Head-Medical Affairs by BioMarin Pharmaceutical, Inc. He received his MBA from The Trustees of Columbia University in The City of New York and a doctorate degree from Drexel University College of Medicine.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-06-2026 | 4.000 ( 0,01% ) | 372 040 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 11-09-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2022 |
| BIOMARIN PHARMACEUTICAL INC. | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University College of Medicine
Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau